International study group on rectal cancer regression grading: Interobserver variability with commonly used regression grading systems

Human Pathology

Volumn 43, Issue 11, 2012, Pages 1917-1923

  Chetty, Runjan ^a   Gill, Pelvender ^a   Govender, Dhirendra ^b   Bateman, Adrian ^c   Chang, Hee Jin ^d   Deshpande, Vikram ^e   Driman, David ^f   Gomez, Marisa ^g   Greywoode, Godman ^a   Jaynes, Eleanor ^c   Lee, C Soon ^h   Locketz, Michael ^b   Rowsell, Corwyn ⁱ   Rullier, Anne ^j   Serra, Stefano ^k   Shepherd, Neil ^l   Szentgyorgyi, Eva ^k   Vajpeyi, Rajkumar ^k   Wang, Lai Mun ^a   Bateman, Andrew ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d National Cancer Center   (South Korea)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g Universidad Pública de Navarra   (Spain)

^h UNIVERSITY OF WESTERN SYDNEY   (Australia)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HEALTH NETWORK   (Canada)

^l CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

Neoadjuvant chemoradiation; Rectal cancer; Regression grading

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL IMAGING; GASTROINTESTINAL PATHOLOGIST; HUMAN; HUMAN TISSUE; INTERRATER RELIABILITY; LONG TERM CARE; MODIFIED RECTAL CANCER REGRESSION GRADING; PATHOLOGIST; PREDICTIVE VALUE; RADIATION DOSE; RATING SCALE; RECTUM CANCER; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TISSUE SECTION;

ADENOCARCINOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTERNATIONAL COOPERATION; NEOADJUVANT THERAPY; NEOPLASM GRADING; OBSERVER VARIATION; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84867892649     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.01.020     Document Type: Article

References (21)

1. S. Pucciarelli, P. Toppan, and M.L. Friso Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome Dis Colon Rectum 47 2004 1798 1807
2. J.S. Shin, B. Jalaludin, M. Solomon, A. Hong, and C.S. Lee Histopathological regression grading versus staging of rectal cancer following radiotherapy Pathology 43 2011 24 30
3. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
4. M.C. Kaminsky-Forrett, T. Conroy, and E. Luporsi Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer Int J Radiat Oncol Biol Phys 42 1998 935 941
5. M. Mohiuddin, M. Hayne, and W.F. Regine Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 2000 1075 1080
6. D. Medich, J. McGinty, and D. Parda Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma Dis Colon Rectum 44 2001 1123 1128
7. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations Cancer 73 1994 2680 2686
8. O. Dworak, L. Keilholz, and A. Hoffmann Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1997 19 23
9. J.M.D. Wheeler, E. Dodds, and B.F. Warren Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade Dis Colon Rectum 47 2004 2025 2031
10. A.C. Bateman, E. Jaynes, and A.R. Bateman Rectal cancer staging post neoadjuvant therapy - how should the changes be assessed? Histopathology 54 2009 713 721
11. R. Ryan, D. Gibbons, and J.M.P. Hyland Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer Histopathology 47 2005 141 146
12. G.T. Williams, P. Quirke, and N.A. Shepherd Dataset for colorectal cancer 2nd ed. 1998 The Royal College of Pathologists London http://www.rcpath.org/ resources/pdf/G049-ColorectalDataset Accessed on 01/12/2012
13. V. Valentini, C. Aristei, and B. Glimelius Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
14. K.M. Bower Measurement system analysis with attribute data. 2011 http://www.minitab.com/uploadedFiles/Shared-Resources/Documents/Articles/ measurement-system-analysis-attribute-data.pdf Accessed on 01/12/2012
15. S. Siegel, and N.J. Castellan Jr Nonparametric statistics for the behavioural sciences 2nd ed. 1998 McGraw-Hill New York
16. M.G. Kendall, and J.D. Gibbons Rank correlation methods 5th ed. 1990 Oxford University Press Oxford, UK
17. D.G. Altman Practical statistics for medical research 1990 Chapman & Hall London
18. C. Capirci, V. Valentini, and L. Cionini Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys 72 2008 99 107
19. H.M. Quah, J.F. Chou, and M. Gonen Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Cancer 113 2008 57 64
20. K.H. Brettingham-Moore, C.P. Duong, and D.M. Greenawalt Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma Clin Cancer Res 17 2011 3039 3047
21. R. Glynne-Jones, and D. Sebag-Montefiore Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer? J Clin Oncol 28 2010 e579 80